Purpose: To compare self-regulation of lowfrequency EEG components (slow cortical potentials, SCPs) with other methods of seizure control for patients with drugrefractory partial epilepsy and to separate the real anticonvulsive effect from placebo effects.
Negative shifts of slow EEG changes (slow cortical potentials: SCPs) reflect widespread depolarization of apical dendrites of pyramidal neurons (1) and decrease of thresholds for paroxysmal activity. On this premise, learning to suppress negative SCP shifts was introduced by Birbaumer et al. (2) as an adjunctive treatment for drug-refractory epilepsy. Learning uses operant control of SCPs, which has previously been extensively tested with healthy populations (3) . Epilepsy patients have also been shown to be able to acquire these self-control skills after many training sessions, and skill acquisition resulted in a significant decrease of the seizure rate (4).
These results have recently been replicated in another sample of patients with intractable epilepsy (5, 6) .
However, a problem with the interpretation of these data consists of adequate control of placebo effects. In the treatment of psychiatric and neurologic disorders with psychoactive pharmacologic agents, the "blindness" of so-called blind and double-blind designs is questionable because patients as well as therapists recognize verum and placebo after short treatment periods (7) . This is particularly true for antiepileptic medication (AEDs), in which positive effects such as seizure reduction as well as negative side effects are easy to perceive. In the domain of behavioral treatments (to which the method of SCP self-control belongs), double-blind studies are impossible and inappropriate. Behavioral interventions involve a high intensity of patient-therapist interaction, which exclude blindness regarding active ingredients of the methods used. A comparison against a condition that is obviously useless or questionable (e.g., learning of self-control over some irrelevant physiologic function) is difficult to defend.
Birbaumer et al. ( 2) compared two groups, one of which acquired the control over their SCPs, and the other was trained to regulate the power of their alpha-rhythms recorded from the same vertex electrode. Seizure activity did not change in this alpha-group after several sessions, and the control condition had to be abandoned for ethical reasons. Both patients and therapists, supposedly "double blind," had clearly recognized their group assignment, and patients as well as "blind" therapists refused to continue therapy under the control condition. Crossover designs [see (8) , for biofeedback of the sensorimotor EEG rhythm] with a waiting-list control condition allow a comparison with no treatment but do not exclude the effects of positive-or negative-outcome expectations.
In the present study, several approaches to solve the problem of placebo control for the SCP self-regulation condition were introduced. First, reduction in seizure frequency after a program of SCP self-regulation training was compared with that of two other groups of patients. One of the groups received a successful antiepileptic therapy for drug-refractory patients in a specialized Epilepsy Center (Kehl). The definition of a patient as "drugresistant" (9, 10) cannot imply that all possible kinds and combinations of AEDs have already been tested. The program realized in the Epilepsy Center Kehl entailed new AEDs, on the one hand, and the entire spectrum of psychosocial counseling, on the other hand. The other group of patients received biofeedback of respiration parameters whose efficacy in the treatment of partial seizures was reported by Fried et al. (11, 12) . These patients learned to increase the end-tidal carbon dioxide and simultaneously to decrease breathing rate.
Second, and most important, during the course of therapy, patients in all three groups reported a set of parameters related to placebo components of the therapeutic effects. Patients estimated their subjective satisfaction with the treatment, the trust they felt in their therapists, the competence of the therapists and their ability to understand patients' problems, and their (i.e., patients') intention to recommend this kind of therapy to other patients. Should the placebo effect play an important role in the reduction of seizures during treatment, the difference between any two groups in terms of clinical improvement would significantly covary with a difference between the same groups at least in one of these measures. A change in positive (i.e., placebo) expectations may be the cause or the consequence of seizure reduction; however, any significant correlation with expectations would at least raise the suspicion that placebo effects interact with active nonplacebo ingredients.
Third, before as well as after the end of treatment, several cognitive and personality variables, life satisfaction, and coping strategies were assessed with a battery of psychological tests. The dynamics of these variables after SCP training in comparison with the other groups delivers additional information about psychological factors probably responsible for treatment effects.
Thus three hypotheses were tested in the study: (a) patients who learn to control their SCPs are superior in terms of seizure reduction to patients of the two other groups; (b) this change of seizure frequency cannot be explained by psychological characteristics of the patients; and (c) the clinical improvement does not depend on (or covary with) patients' subjective satisfaction with the therapy and therapists and patients' expectation of improvement.
METHODS

Patients
Patients participating in the present study were selected according to following criteria:
• Age between 14 and 55 years.
• Predominantly partial seizures, with seizure frequency being at least two/month.
• At least 2 years of continuous medication with two or more AEDs of the first choice without clinical improvement.
• A constant medication regimen for 2 months before baseline measurements up to a 1-year follow-up after the termination of treatment (except MED group).
• Full-scale IQ >80. As mentioned earlier, we believed that thorough analysis of patients' personality characteristics and coping strategies would shed additional light on the problem of placebo control. The reason for the restriction of IQ range was inability of patients with low IQ to perform the tests used for assessment of these features (see later), although the therapeutic methods as such might be effective in low-intelligence patients as well.
• No psychogenic seizures, no progressive or volumeconsuming brain disease, no psychotic complication, no clinical or neuromorphologic signs of frontal lobe damage.
The sample was subdivided into three groups: SCP self-regulation training (SCP group), respiration feedback (RES group), and change of medication (MED group). Initially there were 41 patients in the SCP group, 12 patients in the RES group, and 11 patients in the MED group. Data of 11 patients were discarded for following reasons: changes in medication regimen in the SCP group and dropout during therapy (two patients in the SCP group), dropout before follow-up (one patient in the RES group, two patients in the SCP group), incomplete seizure diary (one patient in the MED group, one patient in the SCP group), unpredicted responsiveness to drug treatment (one patient in the SCP group), and decision for a neurosurgical intervention (three patients in the MED group, one in the SCP group). This resulted in 34 patients (20 female) in the SCP group, 11 (six female) patients in the RES group, and seven (three female) patients in the MED group.
Group arrangement was not random but tried to follow and maximize patients' positive expectations. This strategy was adopted to comply with ethical guidelines required by the ethical committee of the University of Tüb-ingen Hospital after examination of the study design. Patients and family members were given the choice between the three treatment modalities after a written and careful oral description of the three treatment methods. Uneven distributions among groups was an obvious consequence of this strategy. Therefore, some group differences were present before treatment (see Table 1 ). Post hoc analyses (see Results) did not show any of the pretreatment differences to account for outcome differences.
SCP self-regulation
The training of SCP self-regulation has been described in detail elsewhere (4, 5) . A total of 35 training sessions was subdivided into two phases of 20 and 15 sessions, respectively. Each session consisted of 145 trials and lasted ∼90 min. The first phase lasted for 3 weeks, and the second for 2 weeks. The two phases were separated by an 8-week phase during which patients were instructed to practice at home the strategies they had learned during the first training phase.
During a training session, the patient's SCPs were recorded at the vertex (Cz), referred to two mastoid electrodes shunted over a 10-k⍀ resistance. Time constant was set at 10 s. Mean EEG amplitudes over 500-ms intervals sliding with a 100-ms moving average and online corrected for blinks and vertical eye movements [see (5) , for details of the correction procedure] were presented in form of a moving cursor on a computer screen over a period of 8 s in each trial. Each trial began with the presentation of a letter A or B, which served as a discriminative signal informing the patient whether the cortical potential should be changed in that trial to the negative ("A") or positive ("B") polarity as compared with a 2-s pretrial baseline. Rightward movements of the feedback cursor indicated an SCP change in the required direction, and leftward movements, changes in the opposite direction (i.e., a positive SCP shift, when negativity was required, or vice versa). After 8 s, the letter and the feedback signal disappeared, indicating the end of the trial. Intertrial intervals varied randomly between 2 and 5 s. Trials with required positivity versus negativity were randomly distributed over a session, with cortical positivity being required in 50% (during the first training phase) or 67% (during the second training phase) of all trials. In addition, patients received 15 sessions of behavioral treatment. During these sessions, patients were trained to apply the learned SCP self-regulation skills in real-life situations.
Respiration feedback
The RES group was taught a respiration technique developed and described by Fried (11) . Inpatients (usually 5 weeks of stationary treatment) received 35 training sessions, during which they learned to avoid hyperventilation, which is known to be a seizure-provoking factor. During a session, which lasted for Ն10 min, the exhaled air was collected from the nose by a sample tube and directed to a commercially available gas analyzer "Ohmeda." Patients continuously observed their actual endtidal carbon dioxide (ETCO 2 ) and respiration rate on a computer screen in digital form; the respiration rate was also presented on the same screen in analog form as a function of time. The patients' task was to increase ETCO 2 by 5% and to decrease the respiration rate to 15 per minute. This should result in a decrease of the respiration index, which was calculated, according to Fried (11) , as the respiration rate divided by ETCO 2. This training was complemented by the same behavior therapy as in the SCP group to optimize the transfer of the self-regulation skill acquired during training into everyday life.
Medication group
The MED group consisted of seven inpatients treated for a period of from 6 to 8 weeks. Their therapy consisted of a further modification of the drug regimen, as shown in Table 2 . In addition to the drug therapy, during their stay in the hospital, the patients received daily sessions of art therapy, occupational therapy, physiotherapy, individual and group psychotherapy, and training for social competence.
Psychological assessment
A battery of psychological tests was administered before the beginning of treatment: (a) WAIS, German revised version (HAWIE-R) (13) (24); and (l) test for assessment of stress and coping strategies: UBV (25) .
Immediately after the end of the treatment program, all tests except WAIS were repeated. Six months later, WAIS was repeated also, and the tests (i) to (l) were administered a third time.
Further, patients completed a seizure diary in which they noted each seizure of that day, its duration, its antecedents and consequences, changes of consciousness (disturbance or complete loss), aura symptoms, presence and reactions of others, and so on. All patients were specially trained at the beginning of the program in how to complete the diary.
Finally, at the end of the first and the second week of training as well as during the last two weekends, patients rated their opinions of the competence of their therapists ("Competence" scale), the therapists' empathy for patients' problems ("Understanding" scale), the confidence in their therapists ("Confidence" scale), satisfaction with the therapy ("Satisfaction" scale), and the intention to recommend the treatment to other patients ("Recommendation" scale). The 7-point rating scales were intended to control placebo effects. The patients' answers were sent in sealed envelopes to an investigator who had no contact with the patients and were analyzed after the end of the follow-up only.
RESULTS
Target functions
The dynamics of the target physiologic functions (i.e., respiration variables in the RES group and SCPs in the SCP group), are only briefly reported here, because the focuses of this article are clinical and psychological consequences of these dynamics (see 4-6, for publications focused on the physiologic changes).
At the beginning of the therapy, RES patients were found to be moderately hyperventilating, with the mean respiration rate of 17.0 breaths/min, mean ETCO 2 of 4.97%, and the resulting mean respiration index of 3.45. According to Fried (11) , the corresponding normative values are 12-14 breaths/min for respiration rate, 5.0-5.2 for the end-tidal carbon dioxide, and 2.4-2.7 for respiration index. During training, the respiration rate decreased to 13.1 (p ‫ס‬ 0.01), and the ETCO 2 increased to 5.09% (p ‫ס‬ 0.01). This resulted in a dramatic decrease of the respiration index to 2.59 (p ‫ס‬ 0.002).
As there is no normative data about SCPs and their self-regulation, the patients of the SCP group cannot be directly compared with the normal population. It can be mentioned, however, that most healthy subjects have been reported to achieve statistically significant SCP control during the first two training sessions (3). This achievement was shown by none of the patients, which may indicate their particular difficulties in SCP selfregulation. The corresponding ability was significantly enhanced during training (linear trend: p ‫ס‬ 0.007).
Group comparisons
The three groups were compared before therapy was started by means of a one-way analysis of variance (ANOVA). When a significant F ratio was found, Bonferroni-corrected t tests were used to specify which groups differed from each other. There were no significant between-group differences with respect to gender, localization of the epileptic focus, age, seizure history, and the average seizure rate before the beginning of the study. MED group patients took significantly more AEDs than did the patients of the SCP group [F(2, 49) Table 3 shows the mean rate of simple partial seizures, complex partial and secondarily generalized seizures, as well as all types of seizures combined in the three groups. The total number of seizures is slightly larger than the sum of the first two due to (a very small amount of) other seizure types: primary generalized seizures: grand mal without focal onset, absences, and myoclonic seizures. As can be seen in Table 3 , the seizure rate did not change between the baseline phase and the follow-up in the RES group, but there was a decrease in the MED group (both simple and complex partial seizures) as well as in the SCP group (only simple partial seizures).
Seizures
Because the distribution of seizure frequencies was far from normal, it was impossible to use an ANOVA with raw data to prove the reliability of the difference between the groups. Two alternative techniques were used. First, logarithmically transformed seizure rates were calculated, which resulted in a strong decrement of the skewness of the distribution. A mixed-design two-way ANOVA with logarithmic data revealed a highly significant effect of the within-subject factor, Time [two levels: baseline vs. follow-up: F(1, 48) ‫ס‬ 17.57, p < 0.001], but not of the between-subject factor, Group (F < 1). This indicates, first, that the patients' sample as a whole had fewer seizures in the follow-up phase than in the baseline phase; second, that the overall differences in seizure frequency between the three groups were nonsignificant. Most important, however, was a significant interaction between the factors Time and Group (F(2, 48) ‫ס‬ 3.63, p ‫ס‬ 0.034), which confirmed the impression in Table 3 that the change between pre-and posttreatment values was not uniform in all groups.
Further, a nonparametric median test was carried out with baseline versus follow-up difference scores for the three groups combined. Eighteen of 36 patients of the SCP group and five of seven patients of the MED group, but only two of 11 patients of the RES group had abovemedian values, which resulted in a marginally significant 2 Pre, during the 12-week baseline phase before the beginning of a treatment; post, during the 1-year follow-up phase.
seizures did not reach a 10% significance level, although a tendency might be seen in the MED group data. No change was found in the RES group; rather, a slight increment of the overall seizure rate was recorded (t test with logarithmic data: t ‫ס‬ 1.86, p ‫ס‬ 0.10). Taken together, seizure-frequency data demonstrate consistent trends to a reduction of the rate of simple partial seizures (and of the overall seizure rate mainly determined by simple partial seizures) in the SCP and the MED groups, but not in the RES group. Some changes remained only marginally significant in the MED group, which can be explained by the small sample size. In any case, no substantial differences existed in the outcome between the SCP and MED groups. The results of the RES group were negative. Because the latter group significantly differed (at least from the SCP group) with respect to the performance in several cognitivepsychological tests (IQ, attention, memory, etc.), the question may be posed whether these performance differences are responsible for the difference in seizure frequency.
To answer this question, a subset of 14 SCP patients was selected with cognitive characteristics identical to those in the RES group (which will be referred to as "SCP-like RES" group). The remaining 20 SCP patients will be denoted as "SCP-unlike RES" group. The data of these groups are presented in Table 4 .
A comparison of seizure reduction in the three subsamples (i.e., RES, SCP-like RES, and SCP-unlike RES) resulted in a significant main effect of group: [F(2, 38) ‫ס‬ 4.99, p < 0.05]. Post hoc tests revealed that SCP-like RES patients had a larger reduction of simple partial seizures after treatment than did both the RES group and the SCP-unlike RES group. The results of the latter two groups did not differ significantly. Therefore, if the cognitive performance were the determinant of the clinical improvement, the RES group would be expected to have a larger seizure reduction than the SCP and MED groups. Exactly the opposite was the case.
Psychological changes
As test data were normally distributed, their changes were estimated by means of a mixed-design ANOVA with a between-subject factor Group (three levels) and a repeated-measures factor Time (two levels for most tests except locus of control and coping with stress, which were tested three times). When a significant Group × Time interaction was found, before versus after comparisons were conducted for each group separately using t tests (Bonferroni corrected with N ‫ס‬ 3 for variables measured 3 times) for related samples. GreenhousGeisser epsilons were used for nonsphericity correction of the degrees of freedom when appropriate.
Personality variables
As compared with the baseline phase, patients after treatment were less depressive [ 
Cognitive variables
The only cognitive variable changing over time was the full-scale IQ [F(1, 49) ‫ס‬ 7.04, p ‫ס‬ 0.011] which increased from 100.0 before treatment to 105.3 after treatment. This growth appeared to be stronger in the SCP group (7-point increment; t ‫ס‬ 4.5, p < 0.001) than in the MED and RES groups (1.5 points, t ‫ס‬ 0.38, NS; and 4.5 points, t ‫ס‬ 1.4, NS, respectively), but an interaction Group × Time (see Fig. 3 ) was not significant (p ‫ס‬ 0.12).
Placebo-Control
The five placebo scales were analyzed using a threeway ANOVA with within-subject factors Scale (5 levels) and Time (4 levels) and a between-subject factor Group. Scale was taken as a factor to explore the patients' ability to differentiate between different semantic contents. Main effects of both within-subject factors were significant [F(2.38, 114.1) ‫ס‬ 8.23, p < 0.001; and F(2.18, 104.7) ‫ס‬ 3.63, p ‫ס‬ 0.026, for Scale and Time, respectively; degrees of freedom corrected using GreenhouseGeisser epsilon]. Post hoc Bonferroni comparisons were conducted in Holm's (26) modification, that is, the p values were multiplied by N for the largest difference between the two means, by N − 1 for the second largest difference, etc., where N was the number of contrasts (i.e., N ‫ס‬ 6 for the factor Time and N ‫ס‬ 10 for the factor Scale). These tests revealed that patients estimated their treatment after the fourth week (and in fact, after the end of the therapy) significantly higher than during treatment (p values between 0.018 and 0.097). Further, the scores on the scale "Satisfaction with therapy" were significantly lower than the scores on scales "Confidence" (t ‫ס‬ 3.40, p ‫ס‬ 0.008), "Competence" (t ‫ס‬ 2.68, p ‫ס‬ 0.06), and "Recommendation" (t ‫ס‬ 6.44, p ‫ס‬ 0.01). The scores on the "Recommendation" scale (which indicated the patients' intention to recommend the therapy to other patients) were the highest (t ‫ס‬ 3.20, p ‫ס‬ 0.014; and t ‫ס‬ 4.11, p ‫ס‬ 0.009, when compared with "Confidence" and "Understanding", respectively). These tendencies are illustrated in Fig. 4 . The factors Time and Scale did not
FIG. 2.
Changes in depressive and hypochondrial traits, as measured by MMPI, between the baseline ("pre") and the end of the 6-month follow-up phase ("post"). Whereas depressive tendencies decline in all three groups (main effect of Time), Hypochondria is significantly enhanced in the RES group only (Time × Group interaction).
FIG. 1.
Control attributions in the three groups (SCP, RES, and MED). The time points 1, 2, and 3 correspond to the start of the therapy, the end of the therapy, and 6-month follow-up, respectively.
interact with one another (F <1). The main effect of Group was not significant, nor were its interactions with other factors.
DISCUSSION
Seizure reduction
The first hypothesis of the study stated that drugresistant patients after SCP self-regulation training attain a larger decrease of seizure frequency than do patients in the RES and the MED groups. This hypothesis was only partially supported. No difference was found in the magnitude of seizure decrement after treatment between the SCP and the MED groups. Both groups attained better results than did the patients who learned to control their respiration who did not demonstrate any substantial decrease in seizure frequency.
Successful pharmacologic treatment of patients previously defined as drug-resistant has already been described in the literature (27) and thus should not be surprising. The definition of pharmacoresistance cannot imply that all possible combination of medicaments have been tested (9, 10) . The finding that the observed seizure reduction was almost entirely attained due to simple partial seizures, can be explained by the fact that other kinds of seizures were only scarcely present in our sample. In the SCP group, the overall seizure rate dropped, on average, by one third, and the rate of simple partial seizures, by about one half. This result may indicate that, even though the SCP training did not surpass the new drug therapy, SCP self-regulation treatment can be recommended for patients who have excessive side effects or do not respond to medication. Negative side effects do not exist in psychophysiologic treatment methods such as the one used.
The second hypothesis stated that the between-group differences in seizure reduction cannot be reduced to   FIG. 4 . Changes of placebo scales during treatment. It can be seen that (a) all estimation scores consistently increased with time; (b) patients estimated their "satisfaction" lower than on the other scales; and (c) patients used the highest scores to estimate their intention to recommend the therapy to other patients.
FIG. 3.
Full-scale IQ scores in the three groups (SCP, RES, and MED) before the beginning ("pre") and after the 6-month follow-up ("post").
differences in psychological characteristics and placebos. The RES group, which did not profit from the treatment, was characterized by lower performance in a number of psychological tests. However, when the SCP group was split into patients with high versus low cognitive abilities, it was just the latter group (the less intelligent) who demonstrated a considerable clinical improvement in the SCP group. This may appear surprising because of the implicit positive connotation of the word "intelligence" and the related belief that more intelligent and educated people attain better results in any activity, particularly learning. However, both SCP and respiration-training procedures are based on associative learning, which exists in animal species and does not require any specific "higher" cognitive abilities. Earlier we reported a singlecase study of a callosotomized patient with a full-scale IQ of 74 who was extremely successful in learning to control his SCPs and attained a 40% decrease of his seizure frequency (28) .
The patients with low IQ, poor education, and low scores in memory and attention tests were mostly those with bilateral or multiple epileptic foci, in contrast to patients with a single left or right temporal focus who demonstrated higher cognitive performance. In the SCP group, 10 of the 15 patients with a left focus, two of the nine patients with a right focus, and none of the 10 patients with bilateral and multiple foci completed the program without any improvement. Conversely, five patients with a left temporal focus attained a considerable seizure reduction, and two of them became seizure free. The localization of the focus was thus a very important variable mediating the negative correlation between cognitive performance and seizure reduction. The fact that SCP training reduces seizures in bilateral foci patients supports the view that a physiologic change (reduced cortical and, perhaps, subcortical excitability) mediates the therapeutic effect in this groups, whereas respiratory feedback training does not affect the underlying bilateral pathology. Still, the question remains why SCP training yields very heterogeneous effects in the left focus group with high intellectual performance. One can speculate that left temporal localization may negatively affect perception of time sequences essential for conditioning (29) and, therefore, result in less successful SCP learning. Another supposition may be that the unspecific increase in excitation threshold targeted with a vertex electroderecorded SCP does not reach the left-sided circumscribed excitation waves emanating from the left temporal area. Preliminary work (30) has demonstrated that operant self-control of SCPs is anatomically specific, but the learned modification of cortical function remains at the selected electrode location. If this explanation is correct, one can suppose that some of these patients would profit from a more localized specific training procedure such as self-control from left-temporal subdural electrodes.
Psychological changes
The changes in cognitive and personality variables observed in the course of treatment cannot explain the positive dynamics of seizures in the SCP and MED groups. Some of these changes were identical in all groups. The decrease of depressive tendencies, the shift of control attributions from "powerful others" toward more internality, and the increasing ability for relaxation response in stress conditions all indicate positive changes in the patients' psychologic state. It may be suggested that they are the result of positive therapeutic interactions, which were, albeit in quite different forms, realized in all three groups. Numerous data in the literature indicate that various kinds of behavior therapy result in fewer depressive symptoms, more internal-control orientation, and increased relaxation ability (31) . These changes, however, do not differentiate between the groups with good (i.e., SCP and MED) versus worse (i.e., RES) clinical outcomes.
The increase in general IQ after treatment might be supposed to result from practice with the IQ test. However, the interval between the two test administrations in the present study was 1 year. There is no indication in the literature that effects of practice on WAIS (or its German version, HAWIE-R) can last for such a long time. This IQ increment was most pronounced in the SCP group, although group differences did not attain the conventional significance level. Self-regulation of SCPs over longer periods might positively affect selective attention and thus improve IQ test performance.
Other psychological changes differed between groups. These differences could be explained by (a) mood and personality changes reflecting differential placebo effects; (b) specific behavioral effects of the treatment modalities; or (c) differences in the initial prebaseline level of the corresponding variables.
If (a) is correct, larger before-to-after changes in placebo variables such as positive expectations would be observed in the successful SCP and MED groups than in the unsuccessful RES group. This was not the case, though. The option (b), however, cannot be completely ruled out. The increase of the MMPI Hypochondria score by 15 points in the RES group appears to be an effect of respiration feedback focusing the patients' attention on their bodily processes and thereby heightening their sensitivity to visceral changes, in accordance with Brener's (32,33) theory of biofeedback training effects. The increasing sensitivity to one's own body can manifest itself in the increase of the hypochondrial tendency, as measured by the first MMPI scale. Because perception of brain responses needs extensive practice and does not capture one's attention to such an extent as the perception of respiratory changes, the effect of SCP training on the Hypochondria scale was minimal.
Finally, (c) may be correct for the external locus of control variable. Although all patients demonstrated similar tendencies to more internality, less chance, and powerful others control over time, these changes were more manifested in RES patients who were characterized by pronounced external attributions before training, than in SCP and MED patients whose prebaseline scores were close to the population mean. To summarize, all three treatments used in the present study resulted in a substantial improvement of patients' subjective well-being and better psychological adjustment to the condition of the chronic illness. But this psychological improvement and increased emotional stability were only an unspecific by-product of the attention experienced in a treatment regimen using positive interaction with the therapists; they were not related to the reduction of seizures. Therefore, the differential clinical effect seems to be independent of the dynamics of the psychological variables.
Placebo
The measures of satisfaction with therapy were introduced with the assumption that if a placebo effect plays an important part in the clinical effect (i.e., seizure reduction), a positive correlation between the placebo scales and improvement should be present. Such a correlation has not been found. As therapy progressed, patients' satisfaction with their treatment and the intention to recommend the treatment to other patients increased in all treatment modalities. The "Recommendation" score was particularly high. This may also reflect the fact that patients actively participated in the choice of their treatment rather than being passively distributed among the treatment groups.
The subjective satisfaction was always lower than other items such as the professional merits of therapists or their ability to understand patients' problems. Satisfaction depends not only on the therapists' abilities and the treatment methods they use, but also on the (subjectively estimated) individual ability of patients to apply these methods successfully. With the increasing tendency to an internal locus of control and the decline of the belief in "powerful others," this component of "satisfaction with myself in the therapy" continuously grows, independent of seizure reduction.
Study design
Although one of the intentions of the study was the use of a proper control-group design to test the specific clinical effect of SCP self-regulation treatment, the data indicate that such a design cannot be fully realized. Having a choice between the three kinds of therapy (i.e., SCP training, respiration feedback, and drug therapy), patients selected what corresponded best to their individual experiences, beliefs, and attitudes. Patients who decided to continue the search for new medication were those who already took significantly more AEDs. Whenever behavioral treatment is a choice, a play with open cards is mandatory. One cannot persuade a patient to join a behavioral treatment group if he or she does not believe in the usefulness of this technique. Likewise, patients cannot be persuaded to choose surgery if they prefer more conservative cures. In all these cases, goals and principles of the therapeutic methods and the expected effects cannot be hidden from the patient in a double-blind fashion.
Instead of the doomed-to-failure attempts to find the optimal control group, other control procedures may be suggested. One is the development of elaborated placebo scales for satisfaction and hope, such as used in the present study. Although a component of social desirability is always present in patients' reactions to these scales, the highly significant difference between the scores on different psychological scales clearly indicates the ability of patients to answer according to the particular semantic content, not just according to what is socially desirable. Therefore, further methodologic work should be directed to increasing reliability and validity of placebo scales, rather than to attempts to modify the control-group design.
